Drug Profile
Propafenone extended release - Beijing CoSci Med Tech
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Beijing CoSci Med-Tech
- Class Class Ic antiarrhythmics; Propiophenones
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Atrial fibrillation
Most Recent Events
- 10 Aug 2016 Chemical structure information added
- 22 Jul 2016 Investigation in Atrial fibrillation in China (PO)